Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy

AIM: To evaluate the effects of panretinal photocoagulation (PRP) compared with PRP plus intravitreal bevacizumab (IVB) in patients with high-risk proliferative diabetic retinopathy (PDR) according to the Early Treatment Diabetic Retinopathy Study criteria. METHODS: The data were collected retrospec...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Ophthalmol
Hlavní autoři: Zhou, Ai-Yi, Zhou, Chen-Jing, Yao, Jing, Quan, Yan-Long, Ren, Bai-Chao, Wang, Jian-Ming
Médium: Artigo
Jazyk:Inglês
Vydáno: International Journal of Ophthalmology Press 2016
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154991/
https://ncbi.nlm.nih.gov/pubmed/28003978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2016.12.12
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky